Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Roger that !!
GO AEGY!!
ERBB and PANPACIFIC / Bitcoin
PanPacific's website shows an Altitude Organic Corporation vending machine:
http://www.panpacificinternational.com/#/news/
PanPacific is all about the bitcoin future:
http://www.panpacificinternational.com/#/Bitcoin/
Take a look at Pan Pacific's 'about' page:
http://www.panpacificinternational.com/#/about-10/
From September 2013 filings a glimpse:
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=113796
TRANZBYTE TECHNOLOGY AND NEW DEVELOPMENT DIVISION
The Company has an agreement in principle with its previous spin-out subsidiary,
PanPacific International to purchase proprietary dispensary machines that would only
dispense to consumers over the age of 21 in the USA. The machine design includes
features such as a video monitor and will house two security cameras and a card reader
that will accept payment on a YO!21 debit card for selected merchandise. The Company,
in association with PanPacific International and Vending Design Concepts, created the
design of the machine and is currently the exclusive manufacturer for the proprietary
machines.
Altitude Organix Network, a wholly owned division of the Company, will oversee each
machine to assure that it remains connected to the company’s monitoring headquarters 24
hours a day. Every transaction will be monitored in real time on the Network. Live feeds
from each active machine assure that local law enforcement authorities are contacted in
the event of attempted theft or vandalism or can contact the location manager or supplier
when the machine needs attention.
The planned deployment of the proprietary machines is called “21.” Beta testing of the
machines are being planned to occur before the end of this calendar year. Once rollout begins in 2014,
the automated dispensaries will be part of company’s proprietary Zazzz Network where products will be chosen based on their popularity among adults.
ERBB and PANPACIFIC / Bitcoin
PanPacific's website shows an Altitude Organic Corporation vending machine:
http://www.panpacificinternational.com/#/news/
PanPacific is all about the bitcoin future:
http://www.panpacificinternational.com/#/Bitcoin/
Take a look at Pan Pacific's 'about' page:
http://www.panpacificinternational.com/#/about-10/
From September 2013 filings a glimpse:
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=113796
TRANZBYTE TECHNOLOGY AND NEW DEVELOPMENT DIVISION
The Company has an agreement in principle with its previous spin-out subsidiary,
PanPacific International to purchase proprietary dispensary machines that would only
dispense to consumers over the age of 21 in the USA. The machine design includes
features such as a video monitor and will house two security cameras and a card reader
that will accept payment on a YO!21 debit card for selected merchandise. The Company,
in association with PanPacific International and Vending Design Concepts, created the
design of the machine and is currently the exclusive manufacturer for the proprietary
machines.
Altitude Organix Network, a wholly owned division of the Company, will oversee each
machine to assure that it remains connected to the company’s monitoring headquarters 24
hours a day. Every transaction will be monitored in real time on the Network. Live feeds
from each active machine assure that local law enforcement authorities are contacted in
the event of attempted theft or vandalism or can contact the location manager or supplier
when the machine needs attention.
The planned deployment of the proprietary machines is called “21.” Beta testing of the
machines are being planned to occur before the end of this calendar year. Once rollout begins in 2014,
the automated dispensaries will be part of company’s proprietary Zazzz Network where products will be chosen based on their popularity among adults.
You folks with L2, did you see the big boys/MM here Friday?
Yes rawiron1, that bitcoin stock is how I found the ERBB PanPacific connection, the more I looked the more I see that PanPacific is truly set up for bitcoin and marijuana sales ;)
Bitcoin takes the cash issue off the table for the dispensaries ;)
ERBB and PANPACIFIC / bitcoin
It's coming Rainmaker ~
PanPacific's website shows an Altitude Organic Corporation vending machine,
http://www.panpacificinternational.com/#/news/
PanPacific is all about the bitcoin future:
http://www.panpacificinternational.com/#/Bitcoin/
From September 2013 filings a glimpse:
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=113796
TRANZBYTE TECHNOLOGY AND NEW DEVELOPMENT DIVISION
The Company has an agreement in principle with its previous spin-out subsidiary,
PanPacific International to purchase proprietary dispensary machines that would only
dispense to consumers over the age of 21 in the USA. The machine design includes
features such as a video monitor and will house two security cameras and a card reader
that will accept payment on a YO!21 debit card for selected merchandise. The Company,
in association with PanPacific International and Vending Design Concepts, created the
design of the machine and is currently the exclusive manufacturer for the proprietary
machines.
Altitude Organix Network, a wholly owned division of the Company, will oversee each
machine to assure that it remains connected to the company’s monitoring headquarters 24
hours a day. Every transaction will be monitored in real time on the Network. Live feeds
from each active machine assure that local law enforcement authorities are contacted in
the event of attempted theft or vandalism or can contact the location manager or supplier
when the machine needs attention.
The planned deployment of the proprietary machines is called “21.” Beta testing of the
machines are being planned to occur before the end of this calendar year. Once rollout begins in 2014,
the automated dispensaries will be part of company’s proprietary Zazzz Network where products will be chosen based on their popularity among adults.
Take a look at Pan Pacific's 'about' page:
http://www.panpacificinternational.com/#/about-10/
ERBB / bitcoin / Pan Pacific
From September 2013 filings a glimpse:
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=113796
TRANZBYTE TECHNOLOGY AND NEW DEVELOPMENT DIVISION
The Company has an agreement in principle with its previous spin-out subsidiary,
PanPacific International to purchase proprietary dispensary machines that would only
dispense to consumers over the age of 21 in the USA. The machine design includes
features such as a video monitor and will house two security cameras and a card reader
that will accept payment on a YO!21 debit card for selected merchandise. The Company,
in association with PanPacific International and Vending Design Concepts, created the
design of the machine and is currently the exclusive manufacturer for the proprietary
machines.
Altitude Organix Network, a wholly owned division of the Company, will oversee each
machine to assure that it remains connected to the company’s monitoring headquarters 24
hours a day. Every transaction will be monitored in real time on the Network. Live feeds
from each active machine assure that local law enforcement authorities are contacted in
the event of attempted theft or vandalism or can contact the location manager or supplier
when the machine needs attention.
The planned deployment of the proprietary machines is called “21.” Beta testing of the
machines are being planned to occur before the end of this calendar year. Once rollout begins in 2014,
the automated dispensaries will be part of company’s proprietary Zazzz Network where products will be chosen based on their popularity among adults.
Take a look at Pan Pacific's 'about' page:
http://www.panpacificinternational.com/#/about-10/
ERBB and PANPACIFIC / bitcoin
From September 2013 filings a glimpse:
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=113796
TRANZBYTE TECHNOLOGY AND NEW DEVELOPMENT DIVISION
The Company has an agreement in principle with its previous spin-out subsidiary,
PanPacific International to purchase proprietary dispensary machines that would only
dispense to consumers over the age of 21 in the USA. The machine design includes
features such as a video monitor and will house two security cameras and a card reader
that will accept payment on a YO!21 debit card for selected merchandise. The Company,
in association with PanPacific International and Vending Design Concepts, created the
design of the machine and is currently the exclusive manufacturer for the proprietary
machines.
Altitude Organix Network, a wholly owned division of the Company, will oversee each
machine to assure that it remains connected to the company’s monitoring headquarters 24
hours a day. Every transaction will be monitored in real time on the Network. Live feeds
from each active machine assure that local law enforcement authorities are contacted in
the event of attempted theft or vandalism or can contact the location manager or supplier
when the machine needs attention.
The planned deployment of the proprietary machines is called “21.” Beta testing of the
machines are being planned to occur before the end of this calendar year. Once rollout begins in 2014,
the automated dispensaries will be part of company’s proprietary Zazzz Network where products will be chosen based on their popularity among adults.
Take a look at Pan Pacific's 'about' page:
http://www.panpacificinternational.com/#/about-10/
Great question John, I haven't followed the BancoLibre Network info, I've been following the PanPacific website since I saw their bitcoin participation. That would be the best way to circumvent the entire cash in store and visa/mc/fed issues.
ERBB
From September 2013 filings a glimpse:
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=113796
TRANZBYTE TECHNOLOGY AND NEW DEVELOPMENT DIVISION
The Company has an agreement in principle with its previous spin-out subsidiary,
PanPacific International to purchase proprietary dispensary machines that would only
dispense to consumers over the age of 21 in the USA. The machine design includes
features such as a video monitor and will house two security cameras and a card reader
that will accept payment on a YO!21 debit card for selected merchandise. The Company,
in association with PanPacific International and Vending Design Concepts, created the
design of the machine and is currently the exclusive manufacturer for the proprietary
machines.
Altitude Organix Network, a wholly owned division of the Company, will oversee each
machine to assure that it remains connected to the company’s monitoring headquarters 24
hours a day. Every transaction will be monitored in real time on the Network. Live feeds
from each active machine assure that local law enforcement authorities are contacted in
the event of attempted theft or vandalism or can contact the location manager or supplier
when the machine needs attention.
The planned deployment of the proprietary machines is called “21.” Beta testing of the
machines are being planned to occur before the end of this calendar year. Once rollout begins in 2014,
the automated dispensaries will be part of company’s proprietary Zazzz Network where products will be chosen based on their popularity among adults.
Take a look at Pan Pacific's 'about' page:
http://www.panpacificinternational.com/#/about-10/
ERBB perfect combo of weed and bitcoin !!
From September 2013 filings a glimpse:
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=113796
TRANZBYTE TECHNOLOGY AND NEW DEVELOPMENT DIVISION
The Company has an agreement in principle with its previous spin-out subsidiary,
PanPacific International to purchase proprietary dispensary machines that would only
dispense to consumers over the age of 21 in the USA. The machine design includes
features such as a video monitor and will house two security cameras and a card reader
that will accept payment on a YO!21 debit card for selected merchandise. The Company,
in association with PanPacific International and Vending Design Concepts, created the
design of the machine and is currently the exclusive manufacturer for the proprietary
machines.
Altitude Organix Network, a wholly owned division of the Company, will oversee each
machine to assure that it remains connected to the company’s monitoring headquarters 24
hours a day. Every transaction will be monitored in real time on the Network. Live feeds
from each active machine assure that local law enforcement authorities are contacted in
the event of attempted theft or vandalism or can contact the location manager or supplier
when the machine needs attention.
The planned deployment of the proprietary machines is called “21.” Beta testing of the
machines are being planned to occur before the end of this calendar year. Once rollout begins in 2014,
the automated dispensaries will be part of company’s proprietary Zazzz Network where products will be chosen based on their popularity among adults.
Take a look at Pan Pacific's 'about' page:
http://www.panpacificinternational.com/#/about-10/
ERBB and PanPacific/Bitcoin
From September 2013 filings a glimpse:
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=113796
TRANZBYTE TECHNOLOGY AND NEW DEVELOPMENT DIVISION
The Company has an agreement in principle with its previous spin-out subsidiary,
PanPacific International to purchase proprietary dispensary machines that would only
dispense to consumers over the age of 21 in the USA. The machine design includes
features such as a video monitor and will house two security cameras and a card reader
that will accept payment on a YO!21 debit card for selected merchandise. The Company,
in association with PanPacific International and Vending Design Concepts, created the
design of the machine and is currently the exclusive manufacturer for the proprietary
machines.
Altitude Organix Network, a wholly owned division of the Company, will oversee each
machine to assure that it remains connected to the company’s monitoring headquarters 24
hours a day. Every transaction will be monitored in real time on the Network. Live feeds
from each active machine assure that local law enforcement authorities are contacted in
the event of attempted theft or vandalism or can contact the location manager or supplier
when the machine needs attention.
The planned deployment of the proprietary machines is called “21.” Beta testing of the
machines are being planned to occur before the end of this calendar year. Once rollout begins in 2014,
the automated dispensaries will be part of company’s proprietary Zazzz Network where products will be chosen based on their popularity among adults.
Take a look at Pan Pacific's 'about' page:
http://www.panpacificinternational.com/#/about-10/
ERBB and PanPacific/Bitcoin ;)
http://www.panpacificinternational.com/#/splash/
ERBB Check out Pan Pacific's about page:
http://www.panpacificinternational.com/#/about-10/
Right., Pan Pacific and ERBB are the only bitcoin combo that I know of..
win/win
go ERBB !!
;)
From September 2013 filings a glimpse:
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=113796
TRANZBYTE TECHNOLOGY AND NEW DEVELOPMENT DIVISION
The Company has an agreement in principle with its previous spin-out subsidiary,
PanPacific International to purchase proprietary dispensary machines that would only
dispense to consumers over the age of 21 in the USA. The machine design includes
features such as a video monitor and will house two security cameras and a card reader
that will accept payment on a YO!21 debit card for selected merchandise. The Company,
in association with PanPacific International and Vending Design Concepts, created the
design of the machine and is currently the exclusive manufacturer for the proprietary
machines.
Altitude Organix Network, a wholly owned division of the Company, will oversee each
machine to assure that it remains connected to the company’s monitoring headquarters 24
hours a day. Every transaction will be monitored in real time on the Network. Live feeds
from each active machine assure that local law enforcement authorities are contacted in
the event of attempted theft or vandalism or can contact the location manager or supplier
when the machine needs attention.
The planned deployment of the proprietary machines is called “21.” Beta testing of the
machines are being planned to occur before the end of this calendar year. Once rollout begins in 2014,
the automated dispensaries will be part of company’s proprietary Zazzz Network where products will be chosen based on their popularity among adults.
Take a look at Pan Pacific's 'about' page:
http://www.panpacificinternational.com/#/about-10/
PAN PACIFIC boasts its Hong Kong and US Presence ~
ERBB !!
NEWS!! http://us4.campaign-archive2.com/?u=f8a87e09d84b9653aa8bf9e6e&id=ac40c38e5d&e=8538e4f9
From September 2013 filings a glimpse:
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=113796
TRANZBYTE TECHNOLOGY AND NEW DEVELOPMENT DIVISION
The Company has an agreement in principle with its previous spin-out subsidiary,
PanPacific International to purchase proprietary dispensary machines that would only
dispense to consumers over the age of 21 in the USA. The machine design includes
features such as a video monitor and will house two security cameras and a card reader
that will accept payment on a YO!21 debit card for selected merchandise. The Company,
in association with PanPacific International and Vending Design Concepts, created the
design of the machine and is currently the exclusive manufacturer for the proprietary
machines.
Altitude Organix Network, a wholly owned division of the Company, will oversee each
machine to assure that it remains connected to the company’s monitoring headquarters 24
hours a day. Every transaction will be monitored in real time on the Network. Live feeds
from each active machine assure that local law enforcement authorities are contacted in
the event of attempted theft or vandalism or can contact the location manager or supplier
when the machine needs attention.
The planned deployment of the proprietary machines is called “21.” Beta testing of the
machines are being planned to occur before the end of this calendar year. Once rollout begins in 2014,
the automated dispensaries will be part of company’s proprietary Zazzz Network where products will be chosen based on their popularity among adults.
Take a look at Pan Pacific's 'about' page:
http://www.panpacificinternational.com/#/about-10/
PAN PACIFIC boasts its Hong Kong and US Presence ~
ERBB !!
MNTR has a CANV in it's portfolio, Kannalife is a canv company,
Kannalife is the only company awarded a portion of the US Government owned medical marijuana patent:
KannaLife Sciences HomeCompanyManagementAdvisory BoardNewsContact
The Company
We are a socially responsible, phyto-medical company specializing in the research & development of pharmaceutical products derived from botanical sources.
KannaLife Sciences, Inc. (“KannaLife”), is a bio-pharmaceutical and phyto-medical company involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants. KannaLife Sciences currently holds an exclusive license with National Institutes of Health – Office of Technology Transfer (“NIH-OTT”) for the Commercialization of U.S. Patent #6630507, “Cannabinoids as Antioxidants and Neuroprotectants” (the “’507 Patent”). KannaLife is currently conducting research and development at the Bucks County Pennsylvania Biotechnology Center in Doylestown, PA, for a target drug candidate to treat Hepatic Encephalopathy (“HE”). HE is an oxidative stress related disease that affects the cognitive and behavioral functions, and the wellness of the brain.
Link to US Office of the Federal Register
https://www.federalregister.gov/articles/2011/11/17/2011-29726/prospective-grant-of-exclusive-license-development-of-cannabinoids-and-cannabidiols-based
The Daily Journal of the United States Government
Notice
Prospective Grant of Exclusive License: Development of Cannabinoid(s) and Cannabidiol(s) Based Therapeutics To Treat Hepatic Encephalopathy in Humans.
A Notice by the National Institutes of Health on 11/17/2011
PDF DEV PRINT PUBLIC INSPECTION
Publication Date:
Thursday, November 17, 2011
Agencies:
Department of Health and Human Services
National Institutes of Health
Dates:
Only written comments and/or applications for a license which are received by the NIH Office of Technology Transfer on or before December 19, 2011 will be considered.
Comments Close:
12/19/2011
Entry Type:
Notice
Action:
Notice.
Document Citation:
76 FR 71351
Page:
71351 (1 page)
Document Number:
2011-29726
Shorter URL:
https://federalregister.gov/a/2011-29726
Notice.
SUMMARY
This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR part 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the invention embodied in U.S. Patent 6,630,507, entitled “Cannabinoids as antioxidants and neuroprotectants” and PCT Application Serial No. PCT/US99/08769 and foreign equivalents thereof, entitled “Cannabinoids as antioxidants and neuroprotectants” [HHS Ref. No. E-287-1997/2] to KannaLife Sciences Inc.,which has offices in New York, U.S. This patent and its foreign counterparts have been assigned to the Government of the United States of America.
The prospective exclusive license territory may be worldwide, and the field of use may be limited to:
The development and sale of cannabinoid(s) and cannabidiol(s) based therapeutics as antioxidants and neuroprotectants for use and delivery in humans, for the treatment of hepatic encephalopathy, as claimed in the Licensed Patent Rights.
ERBB & Bitcoin/Pan Pacific International connection:
from July 2013:
Read full article here:
http://www2.thestockmarketwatch.com/newsletters/2013/07/25/erbb-is-my-new-sub-penny-play-with-triple-digit-gain-potential-2/
Tranzbyte Corp. (ERBB)ERBB is a driving force behind Altitude Organic Corporation.Altitude Organic Corporation is the first publicly traded medical marijuana dispensary brand in the world. Beginning in 2009, the company has developed retailing, branding, and commercial cultivating strategies in conjunction with its licensed medical marijuana retail dispensaries operating under the Altitude Organic Medicine brand name.ERBB expects to continue its plan to acquire, hold, or spin out successful divisions in what has been described in previous news releases as “dividend farming,” Companies that qualify and decide to become public on their own will agree to carve out shares for ERBB and its shareholders..PanPacific International, the last Tranzbyte spin-off company which resulted in a dividend to Tranzbyte shareholders under the corporation`s unique “dividend farming” concept, will take over Tranzbyte`s previous headquarters in Scottsdale. PanPacific, now a private company, has begun operations in the new and exploding Bitcoin sector. News of its operations is expected shortly.David Gwyther, Tranzbyte`s president states, “Moving into the new, larger facilities will greatly improve the communication and synergies between Tranzbyte`s subsidiaries and divisions and set us up for rapid expansion.”Mr. Gwyther concludes, “We welcome all shareholders to stop by our new headquarters and chat with our energetic management and staff.”The company also encourages all folks wishing to follow our progress to visit the Tranzbyte website at www.tranzbyte.com and sign up to receive our `Email Alerts` which are sparingly sent to interest-holders periodically. Just click on the orange `contact` button after you arrive at the company`s website or click here (http://tranzbyte.com/#/contact/) to go there directly.
and this from PanPacific International:
http://www.panpacificinternational.com/Bitcoin#/news/
Do we know if Simple PrePay will accept Bitcoin?
PharmaJanes™ allows individuals to purchase Medical Marijuana by means of their Simple Prepay gift card. The card can be reloaded at any time through the Simple Prepay platform and can then be used to purchase any of the medical marijuana products listed on PharmaJanes.
AEGY
;)
http://pharmajanes.com/en/faq
Thanks money, site looks great AEGY !
23 for you ;)
Pricing is attached to products on site., or has that been the case all along? Thanks money6870..
AEGY
For comparison here's a quick look at other high o/s stocks in the liquor, pharmaceutical, and household brand sectors... numbers are rounded off to the most conservative decimal.
BUD... 104.93, o/s 1.6B, mc 168B
HEINY... 32.15, o/s 576M, mc 37B
BEAM... 66.05, 0/s 168M, mc 11B
SAM... 226.40 o/s 8.8M mc 2B
DEO... 128.22 o/s 636M mc 20B
PFE... 30.95 o/s 6.5B mc 197B
MRK... 49.79 o/s 2.9B mc 145B
PG... 80.24 o/s 2.7B mc 214B
LLY... 51.11 o/s 1.1B mc 55B
This sector is uncharted, and so varied. Buying and holding, imo angel investors major institutions will be buying from here on in. Keeping in mind a lot of our pinks have already established the patents, trademarks, websites, brand-names, physical presence, etc for the products and mechanisms that will keep this market going for years to come.
Setting up accounts for the kids in a wide range of ganga stocks ~ Best wishes to all!
HEMP ;)
Thanks Dad ~ you as well !!
For comparison here's a quick look at other high o/s stocks in the liquor, pharmaceutical, and household brand sectors... numbers are rounded off to the most conservative decimal.
BUD... 104.93, o/s 1.6B, mc 168B
HEINY... 32.15, o/s 576M, mc 37B
BEAM... 66.05, 0/s 168M, mc 11B
SAM... 226.40 o/s 8.8M mc 2B
DEO... 128.22 o/s 636M mc 20B
PFE... 30.95 o/s 6.5B mc 197B
MRK... 49.79 o/s 2.9B mc 145B
PG... 80.24 o/s 2.7B mc 214B
LLY... 51.11 o/s 1.1B mc 55B
This sector is uncharted, and so varied. Buying and holding, imo angel investors major institutions will be buying from here on in. Keeping in mind a lot of our pinks have already established the patents, trademarks, websites, brand-names, physical presence, etc for the products and mechanisms that will keep this market going for years to come.
Setting up accounts for the kids in a wide range of ganga stocks ~ Best wishes to all!
SKTO ;)
For comparison here's a quick look at other high o/s stocks in the liquor, pharmaceutical, and household brand sectors... numbers are rounded off to the most conservative decimal.
BUD... 104.93, o/s 1.6B, mc 168B
HEINY... 32.15, o/s 576M, mc 37B
BEAM... 66.05, 0/s 168M, mc 11B
SAM... 226.40 o/s 8.8M mc 2B
DEO... 128.22 o/s 636M mc 20B
PFE... 30.95 o/s 6.5B mc 197B
MRK... 49.79 o/s 2.9B mc 145B
PG... 80.24 o/s 2.7B mc 214B
LLY... 51.11 o/s 1.1B mc 55B
This sector is uncharted, and so varied. Buying and holding, imo angel investors major institutions will be buying from here on in. Keeping in mind a lot of our pinks have already established the patents, trademarks, websites, brand-names, physical presence, etc for the products and mechanisms that will keep this market going for years to come.
Setting up accounts for the kids in a wide range of ganga stocks ~ Best wishes to all!
FITX ;)
For comparison here's a quick look at other high o/s stocks in the liquor, pharmaceutical, and household brand sectors... numbers are rounded off to the most conservative decimal.
BUD... 104.93, o/s 1.6B, mc 168B
HEINY... 32.15, o/s 576M, mc 37B
BEAM... 66.05, 0/s 168M, mc 11B
SAM... 226.40 o/s 8.8M mc 2B
DEO... 128.22 o/s 636M mc 20B
PFE... 30.95 o/s 6.5B mc 197B
MRK... 49.79 o/s 2.9B mc 145B
PG... 80.24 o/s 2.7B mc 214B
LLY... 51.11 o/s 1.1B mc 55B
This sector is uncharted, and so varied. Buying and holding, imo angel investors major institutions will be buying from here on in. Keeping in mind a lot of our pinks have already established the patents, trademarks, websites, brand-names, physical presence, etc for the products and mechanisms that will keep this market going for years to come.
Setting up accounts for the kids in a wide range of ganga stocks ~ Best wishes to all!
ERBB !!
Agreed JayDamien, For comparison here's a quick look at other high o/s stocks in the liquor, pharmaceutical, and household brand sectors... numbers are rounded off to the most conservative decimal.
BUD... 104.93, o/s 1.6B, mc 168B
HEINY... 32.15, o/s 576M, mc 37B
BEAM... 66.05, 0/s 168M, mc 11B
SAM... 226.40 o/s 8.8M mc 2B
DEO... 128.22 o/s 636M mc 20B
PFE... 30.95 o/s 6.5B mc 197B
MRK... 49.79 o/s 2.9B mc 145B
PG... 80.24 o/s 2.7B mc 214B
LLY... 51.11 o/s 1.1B mc 55B
This sector is uncharted, and so varied. Buying and holding, imo angel investors major institutions will be buying from here on in. Keeping in mind a lot of our pinks have already established the patents, trademarks, websites, brand-names, physical presence, etc for the products and mechanisms that will keep this market going for years to come.
Setting up accounts for the kids in a wide range of ganga stocks ~ Best wishes to all!
AEGY ;)
CBIS loading more today!! 215 for you Ripdog !!
;)
This looks to be the lowest float mmj stock ~
Thanks Haensys, The Solar panel on the BuzzSol looks like a game changer for cells, tablets, laptops,.. technology is liquid and this is the beginning of the next phase of mobility imo. Haven't looked at BuzzBat but will do that today.
Looking forward to that official launch... great time to be in before NPWZ hits the most read, and buzzcloud, etc., and price climbs higher ;)
Good Morning NPWZ, Any thoughts on what Buzzsol is going to be used for?
http://neahpower.com/buzzsol.html
Following NEAH for a year now.. looks like Chris picked the best man for marketing the PowerPlay..
http://www.linkedin.com/in/alexwilliams
Alexander Williams's Overview
Current
Marketing Coordinator at Neah Power Systems
Marketing Consultant at Thermal Exposure
Past
Strategic Partner at The Edge Learning Institute
Sr. Web Producer at Behringer
Creative & Marketing Communications Manager at Lumera
see all
Education
Phillips University
Recommendations
13 people have recommended Alexander
Connections
206 connections
Websites
Portfolio
Alexander Williams' Summary
Specialties
My specialty is in branding, marketing, consumer outreach, web and social media. I have led the quantifiable transformation of many brands.
With over 13 years of experience, I have developed extensive knowledge and intuition. I have experience in nearly every role within a marketing department. I know what to expect and how to manage and motivate people. I know how to measure success and drive business objectives. I believe a Marketing Department should be a Profit Center.
Alexander Williams' Experience
Marketing Coordinator
Neah Power Systems
Public Company; 1-10 employees; Electrical/Electronic Manufacturing industry
January 2013 – Present (9 months) Bothell, WA
Marketing Consultant
Thermal Exposure
September 2002 – Present (11 years 1 month)
Consultant for many companies including Microvision, Mackie Designs, EAW, Alaska Smokehouse, KV2 Audio, Lumera and The Brighton Group. Responsible for logo and identity creation, web development, print collateral, product packaging, internet marketing, campaign execution and photography. Extensive experience in managing multiple projects to completion.
Strategic Partner
The Edge Learning Institute
Privately Held; 1-10 employees; Human Resources industry
January 2012 – December 2012 (1 year)
Strategic Partner in charge of all things made of 1's and 0's.
Sr. Web Producer
Behringer
June 2008 – February 2010 (1 year 9 months)
Primarily responsible for Behringer’s website featuring over 500 products. Overhauled the existing website replacing outdated systems with a cutting-edge content management solution. Developed new corporate design and led the effort to rebrand the 20 year-old, 3000-employee company. Was interim head of Behringer North America (the marketing subsidiary of the holding company) for 6 months in 2009. Played a key role in developing automation systems and strategies that impact every facet of the company, reducing labor and streamlining data flow. Developed a Social Media strategy with measurable results. Positive sentiment towards the company rose from 65% to 85% in 9 months.
Creative & Marketing Communications Manager
Lumera
Public Company; 51-200 employees; LMRA; Nanotechnology industry
September 2006 – June 2008 (1 year 10 months)
Responsible for all corporate communications, advertising and branding elements. Redesigned corporate logo and introduced a new comprehensive style guide for the company. Responsible for advertising research and recommendations. Responsible for driving traffic to website. Worked closely with the product development team on product specifications, particularly software user interface components. Created logos and brand guidelines for several subsidiary and spin-off companies.
Manager of Strategic Media
eMagin
December 2005 – September 2006 (10 months)
Manager of Strategic Media. Chiefly responsible for web campaigns and rich media, including corporate and consumer websites, ad banners, interactive product tours & videos, and e-commerce. Developed corporate intranet, including numerous web-based tools for project management, ISO-9000 compliancy, Quality Assurance and HR. Developed extranet for OEMs, Distributors, and Developers. Worked with Software development on user interface design & graphic design.
Contractor
Microvision
Public Company; 51-200 employees; MVIS; Consumer Electronics industry
2001 – 2002 (1 year)
Web Developer
Mackie
November 2000 – November 2001 (1 year 1 month)
Alexander Williams' Skills & Expertise
Corporate Branding Web Design Social Media Marketing Interactive Marketing Customer Experience Campaign Management Campaign Development Launch Of New Products Print Collateral Design Mergers Marketing Communications Corporate Communications Copywriting Copy Editing point of sale Wordpress CMS Content Management Wireframes Photography
View All (26) Skills
Alexander Williams' Education
Phillips University
English
1994 – 1998
Alexander Williams' Additional Information
Websites:
Portfolio
Interests:
Branding, Marketing, Web Development, Photography, Design
Honors and Awards:
NIRI (National Investor Relations Institute) Best Website, 2007
W3C Silver Award Winner (Best Website), 2007
Contact Alexander for:
71 ~ GO FNMA !!!!!!!!
This quote from Eric Holder "Holder said he’d had “good conversations” with elected leaders in those states, including Washington Gov. Jay Inslee and Attorney General Bob Ferguson.
“We expect our ability to announce a policy relatively soon,” Holder said.
http://seattletimes.com/html/localnews/2020501013_potholderxml.html
This quote from Eric Holder "Holder said he’d had “good conversations” with elected leaders in those states, including Washington Gov. Jay Inslee and Attorney General Bob Ferguson.
“We expect our ability to announce a policy relatively soon,” Holder said.
http://seattletimes.com/html/localnews/2020501013_potholderxml.html
Agree Feddi, This quote from Eric Holder "Holder said he’d had “good conversations” with elected leaders in those states, including Washington Gov. Jay Inslee and Attorney General Bob Ferguson.
“We expect our ability to announce a policy relatively soon,” Holder said.
http://seattletimes.com/html/localnews/2020501013_potholderxml.html
Federal Government Reports Marijuana Effective in Combatting Certain Cancers Reports ADSI
http://www.nbcnews.com/id/51148243/ns/business-press_releases/t/federal-government-reports-marijuana-effective-combatting-certain-cancers-reports-adsi/#.UUG3faVJMsA
LOS ANGELES, March 12, 2013 (GLOBE NEWSWIRE) -- The following is a statement by Advocates for the Disabled and Seriously Ill:
In a recent report, the National Cancer Institute (NCI), part of the Federal government's National Institutes of Health (NIH), stated that marijuana "inhibited the survival of both estrogen receptor–positive and estrogen receptor–negative breast cancer cell lines." The same report showed marijuana slows or stops the growth of certain lung cancer cells and suggested that marijuana may provide "risk reduction and treatment of colorectal cancer."
Referring to the NCI report, Patient Rights attorney Matthew Pappas said, "The Federal government's continuing attack on people prescribed medical cannabis by their doctors is hypocritical considering the benefits reported by its own National Cancer Institute." Pappas represents patients in defending their right to reasonably obtain medical marijuana. The patients contend the Federal government and various municipalities are trying to prevent them from obtaining cannabis for medical purposes in direct contravention of state laws. "Cities that ban dispensaries are denying patients the ability to obtain a medicine the Federal government's National Institutes of Health says fights cancer and they're doing it with the Obama Administration's help." Recently, the City of Los Angeles repealed its ban of medical marijuana collectives after Bill Rosendahl, a member of its city council diagnosed with cancer and prescribed medical marijuana said to fellow council members about the ban, "You want to kill me? You want to throw me under the bus?"
The NCI report also examined whether patients who smoke marijuana rather than ingesting it orally are exposed to a higher risk of lung and certain digestive system cancers. According to the government, 19 studies "failed to demonstrate statistically significant associations between marijuana inhalation and lung cancer." The report also identified a separate study of 611 lung cancer patients that showed marijuana was "not associated with an increased risk of lung cancer or other upper aerodigestive tract cancers and found no positive associations with any cancer type." In the area of prostate cancer, the NCI report was inconclusive and suggested further research was necessary. In its report, the National Cancer Institute also identified a "study of intratumoral injection of delta-9-THC in patients with recurrent glioblastoma" that showed tumor reduction in the test participants.
Despite the Federal government sanctioned and authorized NCI report, Pappas said Congress and the Obama Administration have continued to thwart marijuana research. In an announced effort to displace state medical marijuana laws, the Office of National Drug Control Policy described "medical" marijuana as a "myth" fueling "troubling misconceptions" in documents found on its website. The Federal government appears to be focused on creating more chemical drugs, many of which are the subject of various attorney television commercials seeking out those adversely impacted by those drugs. Pappas said both the Drug Enforcement Administration and the Office of National Drug Control Policy continue to assert marijuana lacks any medicinal value despite the research showing cannabis reduces certain cancer risks and inhibits the growth of tumor cells. He also commented that the Federal government's anti-marijuana position contributes to and encourages prejudice and public misconception about the legitimate use of medical cannabis as treatment for seriously ill patients.
In addition to anti-cancer properties, separate research reported marijuana appears to have "profound nerve-protective and brain-enhancing properties that could potentially treat many neurodegenerative disorders." In its report, the National Cancer Institute stated cannabis effectively treats insomnia and referenced a placebo-controlled study in cancer patients showing increased quality of sleep and relaxation in those treated with tetrahydrocannabinol, an active component in marijuana.
Responding to a White House statement that only a small percentage of patients prescribed medical cannabis under state laws use it to treat cancer, Pappas said "marijuana isn't just for cancer or AIDS patients – it can also treat, for example, sleeplessness." Although generally not a life threatening condition, Pappas referred to insomnia as a health issue regularly treated with prescription drugs zolpidem (brand name Ambien) and eszopiclone (brand name Lunesta). According to their manufacturers' websites, zolpidem and eszopiclone have been shown to cause severe side effects including aggressiveness, hallucinations, confusion, or suicidal thoughts. Pappas noted that, unlike those drugs, studies on insomnia similar to those reported by the National Cancer Institute show medical marijuana effectively treats insomnia at a far lower cost and with fewer side effects. Marijuana has also been prescribed for glaucoma, multiple sclerosis, chronic pain, and a variety of other physical and mental conditions.
Advertise | AdChoices
Addressing the White House website statement that medical marijuana should remain criminally illegal under federal law, Pappas said that "with every drug, the doctor must consider the benefits versus any possible side effects. In its 3000-plus year history of medicinal use, there has never been a known, confirmed death caused by overdose of marijuana. To suggest that prescription drugs known to have severe negative side effects are alright and that marijuana can only be used for cancer or AIDS is nonsensical. It demonstrates how the Federal government's decision to usurp state sovereignty is harming people because burdening citizens with federal criminal records based on medical marijuana provided for under state law is simply wrong. To continue outlawing the use of a drug shown to have life-saving, anti-cancer benefits that has been used safely as a medication for thousands of years is irresponsible."
Jan., 2013 National Cancer Institute PDQ® report on cannabis:
www.cancer.gov/cancertopics/pdq/cam/cannabis/healthprofessional/page2
July, 2009 NIH report on cannabis reducing neck and head squamous cell carcinoma:
www.ncbi.nlm.nih.gov/pubmed/19638490
Nov., 2012 NIH report on cannabis breast cancer treatment:
www.ncbi.nlm.nih.gov/pubmed/22776349
Report on study showing smoked marijuana does not cause cancer:
www.washingtonpost.com/wp-dyn/content/article/2006/05/25/AR2006052501729.html
Report on neuroprotective benefits of marijuana:
www.foxnews.com/health/2012/03/20/researchers-study-neuroprotective-properties-in-cannabis/
White House "Fact Sheet" on Marijuana Legalization:
Federal Government Reports Marijuana Effective in Combatting Certain Cancers Reports ADSI
http://www.nbcnews.com/id/51148243/ns/business-press_releases/t/federal-government-reports-marijuana-effective-combatting-certain-cancers-reports-adsi/#.UUG3faVJMsA
LOS ANGELES, March 12, 2013 (GLOBE NEWSWIRE) -- The following is a statement by Advocates for the Disabled and Seriously Ill:
In a recent report, the National Cancer Institute (NCI), part of the Federal government's National Institutes of Health (NIH), stated that marijuana "inhibited the survival of both estrogen receptor–positive and estrogen receptor–negative breast cancer cell lines." The same report showed marijuana slows or stops the growth of certain lung cancer cells and suggested that marijuana may provide "risk reduction and treatment of colorectal cancer."
Referring to the NCI report, Patient Rights attorney Matthew Pappas said, "The Federal government's continuing attack on people prescribed medical cannabis by their doctors is hypocritical considering the benefits reported by its own National Cancer Institute." Pappas represents patients in defending their right to reasonably obtain medical marijuana. The patients contend the Federal government and various municipalities are trying to prevent them from obtaining cannabis for medical purposes in direct contravention of state laws. "Cities that ban dispensaries are denying patients the ability to obtain a medicine the Federal government's National Institutes of Health says fights cancer and they're doing it with the Obama Administration's help." Recently, the City of Los Angeles repealed its ban of medical marijuana collectives after Bill Rosendahl, a member of its city council diagnosed with cancer and prescribed medical marijuana said to fellow council members about the ban, "You want to kill me? You want to throw me under the bus?"
The NCI report also examined whether patients who smoke marijuana rather than ingesting it orally are exposed to a higher risk of lung and certain digestive system cancers. According to the government, 19 studies "failed to demonstrate statistically significant associations between marijuana inhalation and lung cancer." The report also identified a separate study of 611 lung cancer patients that showed marijuana was "not associated with an increased risk of lung cancer or other upper aerodigestive tract cancers and found no positive associations with any cancer type." In the area of prostate cancer, the NCI report was inconclusive and suggested further research was necessary. In its report, the National Cancer Institute also identified a "study of intratumoral injection of delta-9-THC in patients with recurrent glioblastoma" that showed tumor reduction in the test participants.
Despite the Federal government sanctioned and authorized NCI report, Pappas said Congress and the Obama Administration have continued to thwart marijuana research. In an announced effort to displace state medical marijuana laws, the Office of National Drug Control Policy described "medical" marijuana as a "myth" fueling "troubling misconceptions" in documents found on its website. The Federal government appears to be focused on creating more chemical drugs, many of which are the subject of various attorney television commercials seeking out those adversely impacted by those drugs. Pappas said both the Drug Enforcement Administration and the Office of National Drug Control Policy continue to assert marijuana lacks any medicinal value despite the research showing cannabis reduces certain cancer risks and inhibits the growth of tumor cells. He also commented that the Federal government's anti-marijuana position contributes to and encourages prejudice and public misconception about the legitimate use of medical cannabis as treatment for seriously ill patients.
In addition to anti-cancer properties, separate research reported marijuana appears to have "profound nerve-protective and brain-enhancing properties that could potentially treat many neurodegenerative disorders." In its report, the National Cancer Institute stated cannabis effectively treats insomnia and referenced a placebo-controlled study in cancer patients showing increased quality of sleep and relaxation in those treated with tetrahydrocannabinol, an active component in marijuana.
Responding to a White House statement that only a small percentage of patients prescribed medical cannabis under state laws use it to treat cancer, Pappas said "marijuana isn't just for cancer or AIDS patients – it can also treat, for example, sleeplessness." Although generally not a life threatening condition, Pappas referred to insomnia as a health issue regularly treated with prescription drugs zolpidem (brand name Ambien) and eszopiclone (brand name Lunesta). According to their manufacturers' websites, zolpidem and eszopiclone have been shown to cause severe side effects including aggressiveness, hallucinations, confusion, or suicidal thoughts. Pappas noted that, unlike those drugs, studies on insomnia similar to those reported by the National Cancer Institute show medical marijuana effectively treats insomnia at a far lower cost and with fewer side effects. Marijuana has also been prescribed for glaucoma, multiple sclerosis, chronic pain, and a variety of other physical and mental conditions.
Advertise | AdChoices
Addressing the White House website statement that medical marijuana should remain criminally illegal under federal law, Pappas said that "with every drug, the doctor must consider the benefits versus any possible side effects. In its 3000-plus year history of medicinal use, there has never been a known, confirmed death caused by overdose of marijuana. To suggest that prescription drugs known to have severe negative side effects are alright and that marijuana can only be used for cancer or AIDS is nonsensical. It demonstrates how the Federal government's decision to usurp state sovereignty is harming people because burdening citizens with federal criminal records based on medical marijuana provided for under state law is simply wrong. To continue outlawing the use of a drug shown to have life-saving, anti-cancer benefits that has been used safely as a medication for thousands of years is irresponsible."
Jan., 2013 National Cancer Institute PDQ® report on cannabis:
www.cancer.gov/cancertopics/pdq/cam/cannabis/healthprofessional/page2
July, 2009 NIH report on cannabis reducing neck and head squamous cell carcinoma:
www.ncbi.nlm.nih.gov/pubmed/19638490
Nov., 2012 NIH report on cannabis breast cancer treatment:
www.ncbi.nlm.nih.gov/pubmed/22776349
Report on study showing smoked marijuana does not cause cancer:
www.washingtonpost.com/wp-dyn/content/article/2006/05/25/AR2006052501729.html
Report on neuroprotective benefits of marijuana:
www.foxnews.com/health/2012/03/20/researchers-study-neuroprotective-properties-in-cannabis/
White House "Fact Sheet" on Marijuana Legalization:
Agreed Reasonable, and thank you. I think KannaLife has some big things in the works... ; )
You missed the question, the question was "does anyone know anything about this patent" asked here on the MJNA board.. I replied using the most logical explanation relative to MJNA.
I then replied to your reply using MJNA and FCLS 's own PR from this past week. The patent rights have been awarded to one company only. That company is KannaLife, a private company. MJNA and FCLS now have a interest in KannaLife.